Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
patient assistance programs and alternative formulations may provide more appropriate solutions
The need-to-know this morning Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting that the drug led to significant weight loss in a mid-stage trial
Lilly plans to present detailed data from the TRIUMPH-1 master trial at the 86th annual American Diabetes Association Scientific Sessions
:max_bytes(150000):strip_icc()/Simple-7-Day-GLP-1-Friendly-Meal-Plan-for-Beginners-Created-by-a-Dietitian-69f3d02b6c2c41928135df7f0c417552.jpg)
FGFR1 silencing with the FGFR1-specific tyrosine kinase inhibitor PD166866 increased the sensitivity of MDA-MB-231 cells to IGF-Trap treatment in vivo
US$ 20.36
US$ 23.37
US$ 21.88
